Liquid biopsy and therapeutic response: Circulating tumor cell cultures for evaluation of anticancer treatment
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
A patient-derived CTC culture assay for anticancer drug evaluation to guide therapy for personalized treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4 Assay validation with controls. (A) Screening of doxorubicin in microwell assay using MCF-7 cancer cell line. Cultures were imaged in situ after staining with LIVE (calcein-AM; green) and DEAD [ethidium bromide (EtBr); red] under 72 hours of exposure to doxorubicin. Clusters under high drug concentrations are mostly nonviable (red), whereas clusters under low drug concentrations are mostly viable (green). (B) Dose-response curve and corresponding IC50 value (0.78 ± 0.02 μM) of MCF-7 generated from viability results. Representative image shows an MCF-7 cell cluster within a microwell (inset). Scale bars, 50 mm. (C) Scatterplot demonstrating overall high gray values that reflect the absence of clusters from cultures of blood from healthy volunteers. Representative image shows cell debris generated within a microwell from culture of a healthy sample (inset). Scale bars, 50 mm.](https://figures.cochat.ai/paper-figures/7e88543c7fea46f48aab4f2c301110a5/liquid-biopsy-and-therapeutic-response-circulating-tumor-cell-cultures-for-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“composite collagen‐alginate microcapsules laden with breast cancer cells (MCF‐7) were reported to create 3D vascularized tumor spheroids by suspending these core–shell microbeads inside an external stromal cell‐laden collagen matrix”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fortunately, with the development of biofabrication techniques, microfluidic and 3D bioprinting technologies have been employed to create more in vivo‐like perfusable 3D tumor models in the biomimetic matrix.[ 72 , 161 ]”
From 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip (2023) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Such heterogeneity is observed in the cohort of circulating tumor cells (CTCs) [12,13], which can be isolated from the peripheral bloodstream or cultured for further analyses.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [12]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
The cited source says what the claim attributes to it.
In the citing paper
“Formation of cell clusters in the microwells was shown to be inversely correlated with increased drug concentration and therapeutic treatment and this liquid biopsy technique can potentially be used to develop personalized medicine.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [135]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“However, the markers used for CTC detection are not applicable to all its subpopulations (32), partly due to the process of epithelial-tomesenchymal transition (36).”
BackgroundSelf-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367 · cited 2×
“This is a similar observation that has been suggested in previous reports for tumor-associatedmacrophages (22).”
ResultCirculating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Yu, M., Bardia, A., Wittner, B. S., Stott, S. L., Smas, M. E., Ting, D. T., Isakoff, S. J., Ciciliano, J. C., Wells, M. N., Shah, A. M., et al. (2013) · Science · doi:10.1126/science.1228522 · Cited by 2,476
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Continuous inertial focusing, ordering, and separation of particles in microchannels
Di Carlo, D., Irimia, D., Tompkins, R. G., & Toner, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704958104 · Cited by 1,708
Molecular imaging of cancer with positron emission tomography
Gambhir, S. S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc882 · Cited by 1,656 · cited 1×
“Current imaging techniques for cancer evaluation [for example, computed tomography (CT) scan] also suffer from technical limitations (3, 4), which lead to false-negative findings.”
MethodIsolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300 · cited 1×
“Also, the formationof clustersmay correlatewith thepotential ofCTCs to form microemboli, which are associated with heightened metastatic potential and may participate directly in metastasis (49, 50).”
BackgroundCirculating Tumor Cells: Liquid Biopsy of Cancer
Alix-Panabières, C., & Pantel, K. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.194258 · Cited by 1,134
Ozkumur, E., Shah, A. M., Ciciliano, J. C., Emmink, B. L., Miyamoto, D. T., Brachtel, E., Yu, M., Chen, P.-I., Morgan, B., Trautwein, J., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005616 · Cited by 1,086
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M. W., Donaldson, M. C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. (2014) · Science · doi:10.1126/science.1253533 · Cited by 913
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells
Guzman, M. L., Neering, S. J., Upchurch, D., Grimes, B., Howard, D. S., Rizzieri, D. A., Luger, S. M., & Jordan, C. T. (2001) · Blood · doi:10.1182/blood.v98.8.2301 · Cited by 758
Isolation and retrieval of circulating tumor cells using centrifugal forces
Hou, H. W., Warkiani, M. E., Khoo, B. L., Li, Z. R., Soo, R. A., Tan, D. S.-W., Lim, W.-T., Han, J., Bhagat, A. A. S., & Lim, C. T. (2013) · Scientific Reports · doi:10.1038/srep01259 · Cited by 736
Self-citationInertial microfluidics for continuous particle separation in spiral microchannels
Kuntaegowdanahalli, S. S., Bhagat, A. A. S., Kumar, G., & Papautsky, I. (2009) · Lab on a Chip · doi:10.1039/b908271a · Cited by 708
Biomarkers of response and resistance to antiangiogenic therapy
Jain, R. K., Duda, D. G., Willett, C. G., Sahani, D. V., Zhu, A. X., Loeffler, J. S., Batchelor, T. T., & Sorensen, A. G. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.63 · Cited by 572 · cited 1×
“Furthermore, tumor biopsies often fail to reflect the complete cancer gene expression profile (1, 2).”
BackgroundQuantitation of cell shedding into efferent blood of mammary adenocarcinoma.
Butler, T. P., & Gullino, P. M. (1975) · PubMed · Cited by 528
The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis
Zhang, L., Ridgway, L. D., Wetzel, M. D., Ngo, J., Yin, W., Kumar, D., Goodman, J. C., Groves, M. D., & Marchetti, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005109 · Cited by 521
High-throughput and ultra-high-throughput screening: solution- and cell-based approaches
Sundberg, S. (2000) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00051-8 · Cited by 455
Isolation of rare cells from cell mixtures by dielectrophoresis
Gascoyne, P. R. C., Noshari, J., Anderson, T. J., & Becker, F. F. (2009) · ELECTROPHORESIS · doi:10.1002/elps.200800373 · Cited by 436 · cited 1×
“In viewof these factors, others reach out to “labelfree techniques” to selectively obtain CTCs by capitalizing on physical properties such as size (21, 40–42), density (43), or dielectrophoresis (44, 45).”
MethodSieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M., Martens, J. W. M., Gratama, J.-W., Sleijfer, S., & Foekens, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn419 · Cited by 435
Guzman, M. L., Rossi, R. M., Neelakantan, S., Li, X., Corbett, C. A., Hassane, D. C., Becker, M. W., Bennett, J. M., Sullivan, E., Lachowicz, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090621 · Cited by 403
Gupta, V., Jafferji, I., Garza, M., Melnikova, V. O., Hasegawa, D. K., Pethig, R., & Davis, D. W. (2012) · Biomicrofluidics · doi:10.1063/1.4731647 · Cited by 383
Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
Cayrefourcq, L., Mazard, T., Joosse, S., Solassol, J., Ramos, J., Assenat, E., Schumacher, U., Costes, V., Maudelonde, T., Pantel, K., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2613 · Cited by 372
Engineering cellular microenvironments to improve cell-based drug testing
Bhadriraju, K., & Chen, C. S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02273-0 · Cited by 355 · cited 1×
“An efficient and reliable drug screening system for routine clinical use should consider the following factors: (i) minimal requirements for reagents and samples, (ii) cultures simulating in vivo conditions (15), and (iii) simplicity and robustness of the system.”
BackgroundInfluentialKasimir-Bauer, S., Hoffmann, O., Wallwiener, D., Kimmig, R., & Fehm, T. (2012) · Breast Cancer Research · doi:10.1186/bcr3099 · Cited by 284
En Route to Metastasis: Circulating Tumor Cell Clusters and Epithelial-to-Mesenchymal Transition
Aceto, N., Toner, M., Maheswaran, S., & Haber, D. A. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.006 · Cited by 276
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Alunni-Fabbroni, M., & Sandri, M. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.027 · Cited by 250
Three-Dimensional In Vitro Co-Culture Model of Breast Tumor using Magnetic Levitation
Jaganathan, H., Gage, J., Leonard, F., Srinivasan, S., Souza, G. R., Dave, B., & Godin, B. (2014) · Scientific Reports · doi:10.1038/srep06468 · Cited by 231 · cited 2×
“Cultures are maintained as multilayered clusters, which may better reflect the in vivo state of a tumor because of heightened cell density in the presence of clusters or spheroids, which had been shown to reduce penetration of drugs (20).”
BackgroundGiordano, A., Gao, H., Anfossi, S., Cohen, E., Mego, M., Lee, B.-N., Tin, S., De Laurentiis, M., Parker, C. A., Alvarez, R. H., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0460 · Cited by 219
Detection of Circulating Tumor Cells in Blood Using an Optimized Density Gradient Centrifugation
Gertler, R., Rosenberg, R., Fuehrer, K., Dahm, M., Nekarda, H., & Siewert, J. R. (2003) · Recent Results in Cancer Research · doi:10.1007/978-3-642-59349-9_13 · Cited by 212
Design, fabrication and characterization of drug delivery systems based on lab-on-a-chip technology
Nguyen, N.-T., Shaegh, S. A. M., Kashaninejad, N., & Phan, D.-T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.008 · Cited by 210 · cited 1×
“S2), which enabled the mixing of two different chemicals to eight different resulting concentrations (16).”
BackgroundKhoo, B. L., Warkiani, M. E., Tan, D. S.-W., Bhagat, A. A. S., Irwin, D., Lau, D. P., Lim, A. S. T., Lim, K. H., Krisna, S. S., Lim, W.-T., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099409 · Cited by 206
Self-citationDetection and Characterization of Putative Metastatic Precursor Cells in Cancer Patients
Alix-Panabières, C., Vendrell, J.-P., Pellé, O., Rebillard, X., Riethdorf, S., Müller, V., Fabbro, M., & Pantel, K. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.079509 · Cited by 194
Gambarin-Gelwan, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00883-2 · Cited by 184 · cited 1×
“Current imaging techniques for cancer evaluation [for example, computed tomography (CT) scan] also suffer from technical limitations (3, 4), which lead to false-negative findings.”
MethodShort-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
Khoo, B. L., Lee, S. C., Kumar, P., Tan, T. Z., Warkiani, M. E., Ow, S. G. W., Nandi, S., Lim, C. T., & Thiery, J. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3903 · Cited by 167 · cited 5×
“The cells within the cluster were heterogeneous and consisted of both CTCs and a residual portion of WBCs, as characterized in our previous publication (14).”
BackgroundMethodResultInfluentialSelf-citationGene-expression-based prognostic assays for breast cancer
Kim, C., & Paik, S. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.61 · Cited by 155 · cited 1×
“Furthermore, tumor biopsies often fail to reflect the complete cancer gene expression profile (1, 2).”
BackgroundCell-Based Drug Combination Screening with a Microfluidic Droplet Array System
Du, G.-S., Pan, J., Zhao, S.-P., Zhu, Y., den Toonder, J. M. J., & Fang, Q. (2013) · Analytical Chemistry · doi:10.1021/ac400688f · Cited by 153 · cited 1×
“At present, several drug screening systems available for cancer cell lines are often designed for use with multiwell plates (5) or robotics (6).”
BackgroundEx Vivo Culture of CTCs: An Emerging Resource to Guide Cancer Therapy
Maheswaran, S., & Haber, D. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0145 · Cited by 112
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer
Wallwiener, M., Hartkopf, A. D., Baccelli, I., Riethdorf, S., Schott, S., Pantel, K., Marmé, F., Sohn, C., Trumpp, A., Rack, B. K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2382-0 · Cited by 110 · cited 1×
“However, some cancer cell lines derived from the triple-negative breast cancer subtype or others, which are characteristic of normal basal epithelial or adipose cells (32), have been reported to cease expression of any of the distinctmarkers used for CTC identification (38, 39).”
BackgroundThe clinical significance of circulating tumor cells
Pantel, K., & Alix‐Panabières, C. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0737 · Cited by 101
Fang, X., Jiang, H., ZHU, Y. Q., Zhang, L., Fan, Q., & Tian, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3131 · Cited by 85
Lee, J., Lee, H., Lee, B., Choi, W., Choi, H.-Y., & Yoon, J. (2007) · Optics Letters · doi:10.1364/ol.32.002665 · Cited by 70 · cited 1×
“For fabrication of the mold for the bottom layer comprising the array ofmicrowells, we adapted from a process termed “diffuser back-side lithography” (51).”
MethodAre circulating tumor cells predictive of overall survival?
Pantel, K., & Riethdorf, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.23 · Cited by 60
Berthier, E., Warrick, J. W., Yu, H., & Beebe, D. J. (2008) · Lab on a Chip · doi:10.1039/b717423c · Cited by 55 · cited 1×
“To minimize the effects of evaporation (17) for long-term culture, the device was designed to fit into a 150-mm dish, which can be filled with a thin film of phosphate-buffered saline (PBS) or deionized water.”
Background
Research works printed but not linked: 2
- 10.1111/j.1572-0241.2000.02091.x · doi:10.1111/j.1572-0241.2000.02091.x · Paper page
- I. J. Fidler, Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2’-deoxyuridine. J. Natl. Cancer Inst. 45, 773–782 (1970).
Cited by
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Biology, vulnerabilities and clinical applications of circulating tumour cells
Ring, A., Nguyen-Sträuli, B. D., Wicki, A., & Aceto, N. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00536-4 · Cited by 327
Circulating tumor cell isolation for cancer diagnosis and prognosis
Deng, Z., Wu, S., Wang, Y., & Shi, D. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104237 · Cited by 284
Microfluidic modelling of the tumor microenvironment for anti-cancer drug development
Shang, M., Soon, R. H., Lim, C. T., Khoo, B. L., & Han, J. (2019) · Lab on a Chip · doi:10.1039/c8lc00970h · Cited by 227
Self-citationMechanobiology of Tumor Growth
Chaudhuri, P. K., Low, B. C., & Lim, C. T. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00042 · Cited by 192
Self-citation
Metadata
- Authors
- Khoo, B. L., Grenci, G., Jing, T., Lim, Y. B., Lee, S. C., Thiery, J. P., Han, J., & Lim, C. T.
- Affiliations
- Singapore-MIT Alliance for Research and Technology (SG)
- National University of Singapore (SG)
- Corresponding author
- Lim, Chwee Teck
- ORCID
- Venue
- Science Advances
- Published
- 2016-07
- Volume
- 2
- Issue
- 7
- Pages
- e1600274-e1600274
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4956185
- OpenAlex
- W2471117482
- Semantic Scholar
- 4a72640c1b8899f148e8da40a9f771600369426d
- Cited by
- 147
- References
- 52
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 19 · 2022: 21 · 2021: 11 · 2020: 19 · 2019: 22 · 2018: 14 · 2017: 15 · 2016: 4
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Science Advances (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Mechanobiology Institute (ID0ETJBI8533)
- Singapore-MIT Alliance for Research and Technology (ID0EXPBI8534)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- liquid biopsy, circulating tumor cells, CTC clusters, drug response monitoring, anticancer drug screening, metastatic breast cancer, microfluidics, drug resistance, precision oncology
- MeSH terms
- Antineoplastic Agents, Biopsy, Breast Neoplasms, Doxorubicin, Female, Humans, Neoplastic Cells, Circulating, Neoplasm Metastasis, Tumor Cells, Cultured, In Situ Hybridization, Fluorescence, Cell Culture Techniques, Microfluidic Analytical Techniques, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.